BEAM
Price
$21.66
Change
-$0.21 (-0.96%)
Updated
Nov 13 closing price
Capitalization
2.2B
109 days until earnings call
Intraday BUY SELL Signals
PRME
Price
$3.33
Change
-$0.22 (-6.20%)
Updated
Nov 13 closing price
Capitalization
599.3M
Intraday BUY SELL Signals
Interact to see
Advertisement

BEAM vs PRME

Header iconBEAM vs PRME Comparison
Open Charts BEAM vs PRMEBanner chart's image
Beam Therapeutics
Price$21.66
Change-$0.21 (-0.96%)
Volume$3.65M
Capitalization2.2B
Prime Medicine
Price$3.33
Change-$0.22 (-6.20%)
Volume$4.11M
Capitalization599.3M
BEAM vs PRME Comparison Chart in %
View a ticker or compare two or three
VS
BEAM vs. PRME commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and PRME is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (BEAM: $21.66 vs. PRME: $3.33)
Brand notoriety: BEAM and PRME are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 145% vs. PRME: 103%
Market capitalization -- BEAM: $2.2B vs. PRME: $599.3M
BEAM [@Biotechnology] is valued at $2.2B. PRME’s [@Biotechnology] market capitalization is $599.3M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whilePRME’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • PRME’s FA Score: 0 green, 5 red.
According to our system of comparison, both BEAM and PRME are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while PRME’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 7 bearish.
  • PRME’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, PRME is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а -6.44% price change this week, while PRME (@Biotechnology) price change was -20.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.47%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +62.00%.

Reported Earning Dates

BEAM is expected to report earnings on Mar 03, 2026.

Industries' Descriptions

@Biotechnology (+1.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.2B) has a higher market cap than PRME($599M). PRME YTD gains are higher at: 21.575 vs. BEAM (-12.661). PRME has higher annual earnings (EBITDA): -197.38M vs. BEAM (-414.33M). BEAM has more cash in the bank: 1.15B vs. PRME (102M). PRME has less debt than BEAM: PRME (120M) vs BEAM (155M). BEAM has higher revenues than PRME: BEAM (60.3M) vs PRME (4.96M).
BEAMPRMEBEAM / PRME
Capitalization2.2B599M367%
EBITDA-414.33M-197.38M210%
Gain YTD-12.66121.575-59%
P/E RatioN/AN/A-
Revenue60.3M4.96M1,215%
Total Cash1.15B102M1,127%
Total Debt155M120M129%
FUNDAMENTALS RATINGS
PRME: Fundamental Ratings
PRME
OUTLOOK RATING
1..100
59
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
41

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMPRME
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 9 days ago
78%
Bullish Trend about 1 month ago
80%
Declines
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 5 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 3 days ago
76%
Aroon
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signal:
Gain/Loss:
PRME
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BRZIX13.920.07
+0.51%
BlackRock Sust Aware Adg Intl Eq Ins
PSMKX62.290.15
+0.24%
Victory Pioneer Select Mid Cap Growth R6
FHECX15.80N/A
N/A
Fidelity Advisor Real Estate C
CCSGX24.65-0.01
-0.04%
Conestoga SMid Cap Institutional
DCCCX24.84-0.04
-0.16%
Macquarie Small Cap Core C

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
-0.96%
CRSP - BEAM
70%
Closely correlated
-2.07%
RXRX - BEAM
62%
Loosely correlated
-6.88%
NTLA - BEAM
61%
Loosely correlated
-8.64%
PRME - BEAM
61%
Loosely correlated
-6.20%
AXON - BEAM
57%
Loosely correlated
-2.15%
More

PRME and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRME has been loosely correlated with CRSP. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if PRME jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRME
1D Price
Change %
PRME100%
-9.44%
CRSP - PRME
60%
Loosely correlated
-5.47%
BEAM - PRME
60%
Loosely correlated
-2.71%
RXRX - PRME
55%
Loosely correlated
-1.27%
EDIT - PRME
51%
Loosely correlated
+1.50%
ABCL - PRME
48%
Loosely correlated
-1.00%
More